| Mrs Kim Joy Watson, RN | |
|
133 Sandalwood Ave, Mercerville, NJ 08619-2035 | |
| (609) 721-1792 | |
| Not Available |
| Full Name | Mrs Kim Joy Watson |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 133 Sandalwood Ave, Mercerville, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558005876 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR12181700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kim Joy Watson, RN 133 Sandalwood Ave, Mercerville, NJ 08619-2035 Ph: (609) 721-1792 | Mrs Kim Joy Watson, RN 133 Sandalwood Ave, Mercerville, NJ 08619-2035 Ph: (609) 721-1792 |
News Archive
Dr James Norman, MD and his partners at the Norman Parathyroid Center have published a landmark study in this week's Journal of the American College of Surgeons describing how the operation they developed and advocated for more than 19 years has significantly poorer long-term outcomes. The unilateral or "one-side" parathyroid surgical procedure to remove parathyroid tumors from patients suffering from hyperparathyroidism is a dramatic change from the large neck operation that it replaced.
Emergent BioSolutions Inc. today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion's Seattle headquarters on October 28, 2010. The acquisition provides Emergent with multiple, advanced stage candidates in the key disease areas of oncology and autoimmunity as well as access to novel and versatile protein therapeutic platforms.
A team of researchers from McGill University has advanced the scientific understanding of abnormal mineral accumulation in arteries, a complication often seen in patients with chronic kidney disease and diabetes. Mineralized arteries may affect heart functions, leading to death in some instances.
The Institute of Medicine (IOM) of the National Academies of Sciences in the autumn of 2004 was asked by the NIH to review the HIVNET 012 perinatal HIV prevention trial and provide an assessment of the validity of the study results.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.
› Verified 9 days ago
Deborah Lawrence, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 71 Concord Ave, Mercerville, NJ 08619 Phone: 609-584-1458 |